172 related articles for article (PubMed ID: 26680362)
1. Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic acid, in human hepatocellular carcinoma cells.
Roberts JL; He B; Erickson A; Moreau R
Biochim Biophys Acta; 2016 Mar; 1861(3):166-76. PubMed ID: 26680362
[TBL] [Abstract][Full Text] [Related]
2. Chylomicron production is repressed by RPTOR knockdown, R-α-lipoic acid and 4-phenylbutyric acid in human enterocyte-like Caco-2 cells.
He B; Wang Z; Moreau R
J Nutr Biochem; 2022 Oct; 108():109087. PubMed ID: 35691593
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
4. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion.
Butler JA; Hagen TM; Moreau R
Arch Biochem Biophys; 2009 May; 485(1):63-71. PubMed ID: 19232511
[TBL] [Abstract][Full Text] [Related]
5. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
Hu J; Che L; Li L; Pilo MG; Cigliano A; Ribback S; Li X; Latte G; Mela M; Evert M; Dombrowski F; Zheng G; Chen X; Calvisi DF
Sci Rep; 2016 Feb; 6():20484. PubMed ID: 26857837
[TBL] [Abstract][Full Text] [Related]
6. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Liu P; Ge M; Hu J; Li X; Che L; Sun K; Cheng L; Huang Y; Pilo MG; Cigliano A; Pes GM; Pascale RM; Brozzetti S; Vidili G; Porcu A; Cossu A; Palmieri G; Sini MC; Ribback S; Dombrowski F; Tao J; Calvisi DF; Chen L; Chen X
Hepatology; 2017 Jul; 66(1):167-181. PubMed ID: 28370287
[TBL] [Abstract][Full Text] [Related]
7. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
10. Glucose adsorption to chitosan membranes increases proliferation of human chondrocyte via mammalian target of rapamycin complex 1 and sterol regulatory element-binding protein-1 signaling.
Chang SF; Huang KC; Cheng CC; Su YP; Lee KC; Chen CN; Chang HI
J Cell Physiol; 2017 Oct; 232(10):2741-2749. PubMed ID: 28218386
[TBL] [Abstract][Full Text] [Related]
11. Monosialyl Ganglioside GM3 Decreases Apolipoprotein B-100 Secretion in Liver Cells.
Choi H; Jin UH; Kang SK; Abekura F; Park JY; Kwon KM; Suh SJ; Cho SH; Ha KT; Lee YC; Chung TW; Kim CH
J Cell Biochem; 2017 Aug; 118(8):2168-2181. PubMed ID: 28019668
[TBL] [Abstract][Full Text] [Related]
12. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response.
Li H; Min Q; Ouyang C; Lee J; He C; Zou MH; Xie Z
Biochim Biophys Acta; 2014 Sep; 1842(9):1844-54. PubMed ID: 25016145
[TBL] [Abstract][Full Text] [Related]
13. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
14. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition.
Sun D; Liu H; Dai X; Zheng X; Yan J; Wei R; Fu X; Huang M; Shen A; Huang X; Ding J; Geng M
Cancer Lett; 2017 Oct; 406():105-115. PubMed ID: 28687354
[TBL] [Abstract][Full Text] [Related]
15.
He B; Moreau R
Biomedicines; 2020 Aug; 8(8):. PubMed ID: 32824248
[TBL] [Abstract][Full Text] [Related]
16. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
17. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells.
Wan ZY; Tian JS; Tan HW; Chow AL; Sim AY; Ban KH; Long YC
Hepatology; 2016 Oct; 64(4):1289-301. PubMed ID: 27178107
[TBL] [Abstract][Full Text] [Related]
19. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.
Guridi M; Kupr B; Romanino K; Lin S; Falcetta D; Tintignac L; Rüegg MA
Skelet Muscle; 2016; 6():13. PubMed ID: 27004103
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells.
Liang JJ; Oelkers P; Guo C; Chu PC; Dixon JL; Ginsberg HN; Sturley SL
J Biol Chem; 2004 Oct; 279(43):44938-44. PubMed ID: 15308631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
